# Elgia Therapeutics, Inc. — Form D

Elgia Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-05. The offering totals $10.0M, of which $2.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-05-05
- Form: D
- Accession: 0001811122-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $2.3M
- Remaining: $7.7M
- Investors: 2
- Date of first sale: 2020-04-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366256

## Issuer

- Name: Elgia Therapeutics, Inc.
- CIK: 0001811122
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 10686 HUNTERS GLEN DRIVE, SAN DIEGO, CA, 92130
- Phone: 858-336-0916

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Ariel Feldstein | Director | San Diego, CA |
| Brian Hubbard | Director | San Diego, CA |
| Alan Saltiel | Director | San Diego, CA |
| Thomas Coll | Executive Officer | San Diego, CA |
| Ariel Feldstein | Executive Officer | San Diego, CA |
| Alan Saltiel | Executive Officer | San Diego, CA |

## More

- [CIK 1811122 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1811122&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001811122-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.